13F-HR filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 45 holding rows worth $624,441,478.
- Accession
- 0001791827-26-000005
- Filer
- CIK 1791827
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 45 entries on the cover page, a total value of $624,441,478 stated on the cover page (in dollars after the unit check, H1), rows summing to $624,441,478 with VALUE read as dollars as filed, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 2,104,184 | $205,115,856 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 1,398,948 | $99,395,255 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 760,424 | $72,369,552 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 1,700,708 | $37,789,732 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 550,000 | $27,912,500 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 6,299,999 | $21,482,997 | dollars as filed | |
| AKTIS ONCOLOGY INC | 01021M104 | COMMON STOCK | 484,200 | $15,605,766 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 70,000 | $10,697,400 | dollars as filed | |
| MOBIA MED INC | 60705V103 | COMMON STOCK | 798,282 | $10,696,979 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 77,800 | $10,615,032 | dollars as filed | |
| IMMUNIC INC | 4525EP200 | COM NEW | 669,941 | $10,296,993 | dollars as filed | |
| SENSEONICS HOLDINGS INC | 81727U303 | COMMON STOCK | 1,600,000 | $9,088,000 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 924,487 | $9,032,238 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 200,000 | $6,776,000 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 100,000 | $6,735,000 | dollars as filed | |
| TEMPUS AI INC CL A | 88023B103 | Stock | 105,000 | $6,082,650 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 70,000 | $5,476,100 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 519,300 | $5,291,667 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 98,000 | $5,259,660 | dollars as filed | |
| ENCOMPASS HEALTH CORP COM | 29261A100 | Stock | 42,000 | $4,245,360 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 265,934 | $3,869,340 | dollars as filed | |
| NUVECTIS PHARMA INC | 67080T108 | COMMON STOCK | 200,000 | $3,678,000 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 24,000 | $3,654,000 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 80,000 | $3,414,400 | dollars as filed | |
| SATELLOS BIOSCIENCE INC | 80401L803 | COM | 387,769 | $3,014,904 | dollars as filed | |
| ALAMAR BIOSCIENCES INC | 010911105 | COMMON STOCK | 110,000 | $2,979,900 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 4,998,267 | $2,768,540 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 20,000 | $2,526,800 | dollars as filed | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 10,000 | $2,267,900 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 200,000 | $2,170,000 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 60,000 | $1,975,200 | dollars as filed | |
| KAILERA THERAPEUTICS INC | 482931102 | COMMON STOCK | 80,000 | $1,762,400 | dollars as filed | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 50,000 | $1,373,500 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 75,000 | $1,269,000 | dollars as filed | |
| CORVUS PHARMACEUTICALS INC | 221015100 | COM | 80,000 | $1,195,200 | dollars as filed | |
| ODDITY TECH LTD SHS CL A | M7518J104 | Stock | 70,000 | $1,059,100 | dollars as filed | |
| SCYNEXIS INC | 811292309 | COM | 260,206 | $1,059,038 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 75,000 | $996,750 | dollars as filed | |
| Abbott Laboratories | 002824100 | COM | 10,000 | $907,400 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 10,000 | $744,800 | dollars as filed | |
| PELOTON INTERACTIVE INC | 70614W100 | CL A COM | 100,000 | $591,000 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 15,000 | $433,200 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 43,853 | $334,160 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 50,000 | $308,000 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 6,660 | $124,209 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001791827-26-000005 | this filing | 2026-08-14 | acceptance time not in the bulk data set |